D-Wave Quantum Inc. Common StockD-Wave finalized a $100 million CHIPS Act R&D grant agreement with the Commerce Department, with the government taking a minority equity stake.
D-Wave Quantum, Rigetti Computing, and Quantinuum each finalized definitive agreements with the U.S. Department of Commerce on Tuesday for $100 million apiece in CHIPS and Science Act funding, with the federal government taking a minority, non-controlling equity stake in each company as a condition of the grants. The three deals total $300 million and are structured as research-and-development grants under the CHIPS Act. Shares of all three companies rose in premarket trading, with Rigetti up 7.4% to $16.33, D-Wave up 5.4% to $17.48, and Quantinuum up 3.9% to $51.56. D-Wave will use its award to develop a 100,000-qubit annealing system and a 10,000-qubit gate-model system capable of 100 logical qubits. Rigetti will pursue three R&D projects focused on miniaturized readout electronics, a new cryostat architecture, and high-connectivity chip fabrication. Quantinuum will support R&D and domestic quantum semiconductor manufacturing, partnering with GlobalFoundries on 300mm wafer fabrication and with Monarch Quantum on lasers and optical components. These three deals are part of a broader federal effort to award $2 billion across nine quantum computing companies, with IBM receiving the largest share at $1 billion for a quantum chip foundry in Albany, New York.
D-Wave Quantum Inc. Common StockD-Wave finalized a $100 million CHIPS Act R&D grant agreement with the Commerce Department, with the government taking a minority equity stake.
Quantinuum Inc. Class A Common StockQuantinuum finalized a $100 million CHIPS Act R&D grant agreement with the Commerce Department, with the government taking a minority equity stake.
Rigetti Computing IncRigetti finalized a $100 million CHIPS Act R&D grant agreement with the Commerce Department, with the government taking a minority equity stake.
International Business MachinesIBM receives the largest share of the federal quantum effort at $1 billion for a quantum chip foundry in Albany, New York.
Globalfoundries IncQuantinuum will partner with GlobalFoundries on 300mm wafer fabrication for domestic quantum semiconductor manufacturing, a concrete customer/partner deal.
Quantum BioPharma Ltd.Quantinuum will partner with Monarch Quantum on lasers and optical components for its CHIPS Act-funded quantum R&D, implying orders for Monarch.